Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 2 |
2012 | 1 |
2013 | 1 |
2015 | 1 |
2017 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Tumefactive MS lesions under fingolimod: a case report and literature review.
Neurology. 2013 Nov 5;81(19):1654-8. doi: 10.1212/01.wnl.0000435293.34351.11. Epub 2013 Oct 4.
Neurology. 2013.
PMID: 24097813
Review.
Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options.
Wipfler P, Harrer A, Pilz G, Oppermann K, Trinka E, Kraus J.
Wipfler P, et al. Among authors: oppermann k.
Drug Discov Today. 2011 Jan;16(1-2):8-21. doi: 10.1016/j.drudis.2010.10.011. Epub 2010 Nov 3.
Drug Discov Today. 2011.
PMID: 21055477
Review.
Item in Clipboard
Conversion and reversion of anti-John Cunningham virus antibody serostatus: A prospective study.
Auer M, Hegen H, Sellner J, Oppermann K, Bsteh G, Di Pauli F, Berger T, Deisenhammer F.
Auer M, et al. Among authors: oppermann k.
Brain Behav. 2019 Jul;9(7):e01332. doi: 10.1002/brb3.1332. Epub 2019 Jun 6.
Brain Behav. 2019.
PMID: 31168964
Free PMC article.
Item in Clipboard
Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.
Harrer A, Wipfler P, Einhaeupl M, Pilz G, Oppermann K, Hitzl W, Afazel S, Haschke-Becher E, Strasser P, Trinka E, Kraus J.
Harrer A, et al. Among authors: oppermann k.
J Neuroimmunol. 2011 May;234(1-2):148-54. doi: 10.1016/j.jneuroim.2011.03.001. Epub 2011 Mar 29.
J Neuroimmunol. 2011.
PMID: 21450349
Item in Clipboard
From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.
Harrer A, Pilz G, Oppermann K, Sageder M, Afazel S, Haschke-Becher E, Rispens T, de Vries A, McCoy M, Stevanovic V, Hitzl W, Trinka E, Kraus J, Sellner J, Wipfler P.
Harrer A, et al. Among authors: oppermann k.
Clin Immunol. 2017 Mar;176:87-93. doi: 10.1016/j.clim.2017.01.001. Epub 2017 Jan 17.
Clin Immunol. 2017.
PMID: 28108364
Item in Clipboard
Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.
Harrer A, Pilz G, Einhaeupl M, Oppermann K, Hitzl W, Wipfler P, Sellner J, Golaszewski S, Afazel S, Haschke-Becher E, Trinka E, Kraus J.
Harrer A, et al. Among authors: oppermann k.
PLoS One. 2012;7(2):e31784. doi: 10.1371/journal.pone.0031784. Epub 2012 Feb 20.
PLoS One. 2012.
PMID: 22363732
Free PMC article.
Clinical Trial.
Item in Clipboard
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Harrer A, Wipfler P, Pilz G, Oppermann K, Haschke-Becher E, Afazel S, Kraus J, Trinka E, Sellner J.
Harrer A, et al. Among authors: oppermann k.
Int J Mol Sci. 2015 Sep 10;16(9):21832-45. doi: 10.3390/ijms160921832.
Int J Mol Sci. 2015.
PMID: 26378517
Free PMC article.
Item in Clipboard
Cite
Cite